دورية أكاديمية
Macropinocytosis Exploitation by Cancers and Cancer Therapeutics.
| العنوان: | Macropinocytosis Exploitation by Cancers and Cancer Therapeutics. |
|---|---|
| المؤلفون: | Ha KD; Department of Anesthesia, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco San Francisco, CA, USA., Bidlingmaier SM; Department of Anesthesia, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco San Francisco, CA, USA., Liu B; Department of Anesthesia, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco San Francisco, CA, USA. |
| المصدر: | Frontiers in physiology [Front Physiol] 2016 Sep 12; Vol. 7, pp. 381. Date of Electronic Publication: 2016 Sep 12 (Print Publication: 2016). |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101549006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-042X (Print) Linking ISSN: 1664042X NLM ISO Abbreviation: Front Physiol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Lausanne : Frontiers Research Foundation |
| مستخلص: | Macropinocytosis has long been known as a primary method for cellular intake of fluid-phase and membrane-bound bulk cargo. This review seeks to re-examine the latest studies to emphasize how cancers exploit macropinocytosis to further their tumorigenesis, including details in how macropinocytosis can be adapted to serve diverse functions. Furthermore, this review will also cover the latest endeavors in targeting macropinocytosis as an avenue for novel therapeutics. |
| References: | Clin Cancer Res. 2015 Apr 1;21(7):1722-33. (PMID: 25355928) Nat Commun. 2015 Aug 04;6:7939. (PMID: 26239362) Biochim Biophys Acta. 2015 Jun;1851(6):805-23. (PMID: 25238964) J Immunol. 2011 May 1;186(9):5345-55. (PMID: 21421853) PLoS One. 2015 Jul 16;10(7):e0131429. (PMID: 26182353) Mol Biol Cell. 2012 Jul;23 (13):2571-82. (PMID: 22573884) J Cell Sci. 2002 Jul 15;115(Pt 14):2953-62. (PMID: 12082155) Front Physiol. 2015 Feb 16;6:38. (PMID: 25762935) Cell. 2015 Jul 16;162(2):259-70. (PMID: 26144316) Cancer Res. 2015 Feb 1;75(3):544-53. (PMID: 25644265) Int J Med Microbiol. 2002 Feb;291(6-7):487-94. (PMID: 11890548) Nat Cell Biol. 2004 Apr;6(4):319-27. (PMID: 15048123) J Biol Chem. 2005 Jun 17;280(24):22856-67. (PMID: 15757891) Clin Cancer Res. 2015 Apr 15;21(8):1828-34. (PMID: 25878364) Adv Clin Chem. 2016;74:103-41. (PMID: 27117662) Methods Mol Biol. 2008;440:15-33. (PMID: 18369934) J Cell Biol. 1994 Mar;124(5):689-703. (PMID: 8120092) Cancer Sci. 2009 Apr;100(4):770-7. (PMID: 19469020) J Cell Sci. 2009 Jun 1;122(Pt 11):1713-21. (PMID: 19461071) Oncotarget. 2014 Jul 15;5(13):5125-37. (PMID: 25026275) Traffic. 2016 Apr;17 (4):351-68. (PMID: 26650385) Oncogene. 2013 Dec 5;32(49):5541-50. (PMID: 23851494) J Virol. 2011 Jan;85(1):334-47. (PMID: 21047970) J Control Release. 2006 May 15;112(2):229-39. (PMID: 16545478) J Cell Sci. 1992 Aug;102 ( Pt 4):867-80. (PMID: 1429898) J Biol Chem. 2013 Nov 29;288(48):34707-18. (PMID: 24151076) Mol Brain. 2015 Jul 14;8:41. (PMID: 26170135) J Cell Sci. 2001 Jul;114(Pt 14):2673-83. (PMID: 11683394) Medicines (Basel). 2015 Dec;2(4):310-327. (PMID: 27088079) Molecules. 2015 Dec 03;20(12):21569-83. (PMID: 26633348) PLoS Biol. 2004 Sep;2(9):E261. (PMID: 15328530) Immunol Cell Biol. 2011 Nov;89(8):836-43. (PMID: 21423264) Traffic. 2009 Apr;10(4):364-71. (PMID: 19192253) Cell Microbiol. 2015 Jul;17(7):988-1007. (PMID: 25565085) Cancer Res. 2010 Nov 1;70(21):8617-29. (PMID: 20861190) Cancer Lett. 2014 Sep 1;351(2):242-51. (PMID: 24973521) Sci Rep. 2015 Jun 03;5:10300. (PMID: 26036864) Nat Commun. 2016 Apr 06;7:11284. (PMID: 27050483) J Cell Biol. 1982 Jan;92(1):79-91. (PMID: 7199055) J Biol Chem. 2016 Feb 19;291(8):3837-47. (PMID: 26719328) J Cell Biol. 2015 Oct 12;211(1):159-72. (PMID: 26438830) Sci Rep. 2016 Apr 15;6:24567. (PMID: 27080246) Cell Mol Neurobiol. 2016 Apr;36(3):417-27. (PMID: 27017608) Cell. 2014 Apr 10;157(2):313-28. (PMID: 24656405) Front Physiol. 2015 Apr 09;6:106. (PMID: 25914647) Cell. 2016 Mar 10;164(6):1226-32. (PMID: 26967288) Eur J Pharm Biopharm. 2015 Sep;95(Pt A):13-7. (PMID: 25701806) Science. 1996 Dec 20;274(5295):2115-8. (PMID: 8953049) J Clin Invest. 2016 Apr 1;126(4):1224-32. (PMID: 27035813) Can J Microbiol. 2014 Sep;60(9):569-77. (PMID: 25113069) Cancer Res. 2006 Apr 1;66(7):3603-10. (PMID: 16585185) ACS Nano. 2015 Oct 27;9(10):10099-112. (PMID: 26324059) Mol Ther. 2015 Dec;23(12):1888-98. (PMID: 26412588) Cell Signal. 2009 Jan;21(1):1-6. (PMID: 18647649) J Cell Biol. 1989 Dec;109(6 Pt 1):2731-9. (PMID: 2556406) J Neurochem. 2010 Feb;112(4):882-99. (PMID: 19943845) Science. 2015 Nov 27;350(6264):1089-92. (PMID: 26612952) Cell Cycle. 2011 May 15;10(10):1571-81. (PMID: 21478669) FEBS J. 2015 Apr;282(7):1167-81. (PMID: 25645340) Semin Cancer Biol. 2015 Dec;35:145-53. (PMID: 26297892) Cancers (Basel). 2016 Apr 18;8(4):null. (PMID: 27096871) Chem Biol. 2012 Nov 21;19(11):1437-46. (PMID: 23177198) Environ Toxicol Chem. 2014 Mar;33(3):481-92. (PMID: 24273100) Am J Clin Oncol. 2014 Apr;37(2):167-71. (PMID: 23211220) PLoS Pathog. 2016 Apr 25;12(4):e1005595. (PMID: 27110717) Eur J Pharm Biopharm. 2013 Aug;84(3):517-25. (PMID: 23333899) J Cell Biol. 2001 Sep 3;154(5):1007-17. (PMID: 11535619) J Nanobiotechnology. 2014 Oct 30;12:43. (PMID: 25358257) Trends Immunol. 2003 Jun;24(6):320-6. (PMID: 12810108) Nat Cell Biol. 2005 Oct;7(10):969-76. (PMID: 16155590) Annu Rev Biochem. 2009;78:857-902. (PMID: 19317650) Mol Carcinog. 2011 Nov;50(11):901-12. (PMID: 21438025) J Cell Biol. 1993 Jun;121(5):1011-20. (PMID: 8099075) Cancer Cell. 2014 Mar 17;25(3):272-81. (PMID: 24651010) Mol Cell Proteomics. 2014 Dec;13(12):3320-31. (PMID: 25149096) Nature. 2013 May 30;497(7451):633-7. (PMID: 23665962) J Cell Biol. 1996 Aug;134(4):935-47. (PMID: 8769418) Yao Xue Xue Bao. 2012 Apr;47(4):512-6. (PMID: 22799036) Nucleic Acid Ther. 2012 Oct;22(5):360-3. (PMID: 22963044) Curr Opin Cell Biol. 2001 Aug;13(4):485-92. (PMID: 11454456) Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):E3138-47. (PMID: 23898162) FEBS Lett. 2016 Apr;590(7):885-907. (PMID: 26938658) Nanoscale. 2015 Nov 14;7(42):17889-901. (PMID: 26462719) J Drug Target. 2012 Apr;20(3):235-45. (PMID: 22188312) Exp Cell Res. 2012 Dec 10;318(20):2578-91. (PMID: 22975728) J Control Release. 2008 Dec 18;132(3):171-83. (PMID: 18582981) Nat Protoc. 2014 Jan;9(1):182-92. (PMID: 24385148) J Cell Biol. 2010 Feb 22;188(4):547-63. (PMID: 20156964) Mol Oncol. 2015 Nov;9(9):1815-24. (PMID: 26130327) Mol Pharm. 2006 Mar-Apr;3(2):181-6. (PMID: 16579647) J Clin Invest. 2015 Jun;125(6):2307-16. (PMID: 25915582) Biochimie. 2016 Jun;125:250-8. (PMID: 26391221) Cancer Res. 2013 Feb 1;73(3):1156-67. (PMID: 23378476) Proc Natl Acad Sci U S A. 2012 May 8;109(19):E1163-72. (PMID: 22509030) Mol Cancer Res. 2008 Jun;6(6):965-77. (PMID: 18567800) Nature. 2004 May 20;429(6989):309-14. (PMID: 15152255) Med Oncol. 2015 Dec;32(12 ):259. (PMID: 26519258) Biochem Biophys Res Commun. 2006 Sep 22;348(2):379-85. (PMID: 16893522) J Cell Biol. 1996 Dec;135(5):1249-60. (PMID: 8947549) Cell Biol Int Rep. 1989 Dec;13(12):1063-76. (PMID: 2576862) Biomaterials. 2014 Jun;35(17 ):4835-47. (PMID: 24651033) J Cell Sci. 1997 Jan;110 ( Pt 2):105-12. (PMID: 9044041) Immunity. 1995 Dec;3(6):783-91. (PMID: 8777723) Gene Ther. 2007 Apr;14(8):682-9. (PMID: 17268535) Front Physiol. 2015 Oct 16;6:277. (PMID: 26528186) Oncologist. 2014 Jun;19(6):637-8. (PMID: 24821822) PLoS Pathog. 2011 Mar;7(3):e1001329. (PMID: 21483486) J Biol Chem. 2003 Nov 21;278(47):46927-37. (PMID: 12958316) Mol Ther. 2004 Dec;10(6):1011-22. (PMID: 15564133) Science. 2008 Apr 25;320(5875):531-5. (PMID: 18436786) Eur J Cell Biol. 1993 Jun;61(1):44-53. (PMID: 8223707) Nature. 1993 Aug 12;364(6438):639-42. (PMID: 8350922) Proc Natl Acad Sci U S A. 1998 May 26;95(11):6181-6. (PMID: 9600938) Physiol Rev. 2013 Jan;93(1):69-106. (PMID: 23303906) Elife. 2016 Feb 27;5:e10250. (PMID: 26920219) Cytoskeleton (Hoboken). 2016 Feb;73(2):68-82. (PMID: 26801966) Nat Med. 2015 Mar;21(3):288-94. (PMID: 25665179) PLoS One. 2013 Nov 27;8(11):e81903. (PMID: 24312378) Mol Pharm. 2006 Nov-Dec;3(6):644-53. (PMID: 17140252) |
| معلومات مُعتمدة: | R01 CA118919 United States CA NCI NIH HHS; R01 CA129491 United States CA NCI NIH HHS; R01 CA171315 United States CA NCI NIH HHS |
| فهرسة مساهمة: | Keywords: altered membrane dynamics; macropinocytosis; macropinosome; neurodegenerative disease; pathogen entry; receptor-dependent macropinocytosis; targeted cancer therapy; tumor selective internalization |
| تواريخ الأحداث: | Date Created: 20160928 Date Completed: 20160927 Latest Revision: 20220409 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC5018483 |
| DOI: | 10.3389/fphys.2016.00381 |
| PMID: | 27672367 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1664-042X |
|---|---|
| DOI: | 10.3389/fphys.2016.00381 |